WHAT ARE THE KEY PERFORMANCE METRICS THAT AGENCIES AND COMPANIES SHOULD USE TO MEASURE REGULATORY PROCESSES AND PRACTICES TO FACILITATE THE LICENSING OF NEW MEDICINES?
3-4 FEBRUARY 2016, KUALA LUMPUR, MALAYSIA
- Identify and provide the rationale for selecting key regulatory performance areas that agencies and their stakeholders believe should be measured and discuss how this can best be achieved.
- Discuss how agencies and companies actually measure their performance and how this can enable change by improving efficiency, effectiveness and quality of processes and practices.
- Recommend which key performance metrics should be used to help improve the internal performance of companies and agencies to ensure the timely availability of safe and effective medicines.